| Entry |
|
|---|
| Name |
Etaracizumab (USAN/INN);
Abegrin (TN) |
|---|
| Formula |
C6392H9908N1732O1996S42
|
|---|
| Exact mass |
144211.5312
|
|---|
| Mol weight |
144300.28
|
|---|
| Efficacy |
Antineoplastic, Angiogenesis inhibitor, Anti-alpha-v-beta-3 antibody |
|---|
| Type |
Monoclonal antibody |
|---|
| Comment |
Treatment of metastatic melanoma, prostate cancer
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04810 | Regulation of actin cytoskeleton |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Cell adhesion molecules: other families
Integrins
ITGAV/ITGB3
D09342 Etaracizumab (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
